These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9734710

  • 1. Endothelin converting enzyme inhibitor protects development of right ventricular overload and medial thickening of pulmonary arteries in rats with monocrotaline-induced pulmonary hypertension.
    Takahashi T, Kanda T, Inoue M, Sumino H, Kobayashi I, Iwamoto A, Nagai R.
    Life Sci; 1998; 63(10):PL137-43. PubMed ID: 9734710
    [Abstract] [Full Text] [Related]

  • 2. Amlodipine inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.
    Takahashi T, Kanda T, Imai S, Suzuki T, Kobayashi I, Nagai R.
    Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):17-32. PubMed ID: 8824928
    [Abstract] [Full Text] [Related]

  • 3. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Guerard P, Rakotoniaina Z, Goirand F, Rochette L, Dumas M, Lirussi F, Bardou M.
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
    [Abstract] [Full Text] [Related]

  • 4. A selective type V phosphodiesterase inhibitor, E4021, protects the development of right ventricular overload and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.
    Takahashi T, Kanda T, Inoue M, Suzuki T, Kobayashi I, Kodama K, Nagai R.
    Life Sci; 1996 Sep; 59(23):PL 371-7. PubMed ID: 8950302
    [Abstract] [Full Text] [Related]

  • 5. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M, Hasegawa Y, Tanida I, Nakagawa E, Inaji H, Ohkita M, Matsumura Y.
    Eur J Pharmacol; 2009 Jul 01; 614(1-3):70-6. PubMed ID: 19379725
    [Abstract] [Full Text] [Related]

  • 6. Protective effects of drag-reducing polymers in a rat model of monocrotaline-induced pulmonary hypertension.
    Wang Y, Hu F, Mu X, Wu F, Yang D, Zheng G, Sun X, Gong K, Zhang Z.
    Biorheology; 2016 Jan 27; 53(1):13-22. PubMed ID: 26889655
    [Abstract] [Full Text] [Related]

  • 7. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
    Miyauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, Yano M, Yamaguchi I, Sugishita Y, Goto K.
    Circ Res; 1993 Nov 27; 73(5):887-97. PubMed ID: 8403258
    [Abstract] [Full Text] [Related]

  • 8. Semotiadil inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.
    Takahashi T, Kanda T, Imai S, Suzuki T, Kobayashi I, Murata K.
    Cardiovasc Drugs Ther; 1995 Dec 27; 9(6):809-14. PubMed ID: 8850386
    [Abstract] [Full Text] [Related]

  • 9. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP, Dai ZK, Huang CH, Yeh JL, Wu BN, Wu JR, Chen IJ.
    Kaohsiung J Med Sci; 2014 Jun 27; 30(6):267-78. PubMed ID: 24835346
    [Abstract] [Full Text] [Related]

  • 10. Monocrotaline-induced structural remodeling of the intra-acinar pulmonary arteries and pulmonary hypertension.
    Li WY, Che DY.
    J Tongji Med Univ; 1992 Jun 27; 12(4):227-33. PubMed ID: 1289571
    [Abstract] [Full Text] [Related]

  • 11. Gene transfer of hepatocyte growth factor with prostacyclin synthase in severe pulmonary hypertension of rats.
    Ono M, Sawa Y, Fukushima N, Suhara H, Nakamura T, Yokoyama C, Tanabe T, Matsuda H.
    Eur J Cardiothorac Surg; 2004 Dec 27; 26(6):1092-7. PubMed ID: 15541968
    [Abstract] [Full Text] [Related]

  • 12. Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline.
    Yoshihara F, Nishikimi T, Horio T, Yutani C, Takishita S, Matsuo H, Ohe T, Kangawa K.
    Eur J Pharmacol; 1998 Aug 14; 355(1):33-9. PubMed ID: 9754936
    [Abstract] [Full Text] [Related]

  • 13. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S, Ellinghaus P, Janssen W, Kramer F, Lustig K, Milting H, Kast R, Klein M.
    Cardiovasc Res; 2009 Apr 01; 82(1):30-9. PubMed ID: 19131365
    [Abstract] [Full Text] [Related]

  • 14. Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.
    Rakotoniaina Z, Guerard P, Lirussi F, Rochette L, Dumas M, Goirand F, Bardou M.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Sep 01; 378(3):241-51. PubMed ID: 18542928
    [Abstract] [Full Text] [Related]

  • 15. Cardioprotective effect of cerium oxide nanoparticles in monocrotaline rat model of pulmonary hypertension: A possible implication of endothelin-1.
    Nassar SZ, Hassaan PS, Abdelmonsif DA, ElAchy SN.
    Life Sci; 2018 May 15; 201():89-101. PubMed ID: 29588134
    [Abstract] [Full Text] [Related]

  • 16. Sandostatin inhibits development of medial proliferation of pulmonary arteries in a rat model of pulmonary hypertension.
    Takahashi T, Kanda T, Imai S, Suzuki T, Murata K.
    Life Sci; 1995 May 15; 57(8):PL91-5. PubMed ID: 7637546
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
    Hill NS, Warburton RR, Pietras L, Klinger JR.
    J Appl Physiol (1985); 1997 Oct 15; 83(4):1209-15. PubMed ID: 9338430
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
    Liu H, Liu ZY, Guan Q.
    Interact Cardiovasc Thorac Surg; 2007 Oct 15; 6(5):608-13. PubMed ID: 17670742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.